Posttransplant Cyclophosphamide and Antithymocyte Globulin versus Posttransplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis for Peripheral Blood Stem Cell Haploidentical Transplants: Comparison of T Cell and NK Effector Reconstitution-Reference-Cited by-同舟云学术

Posttransplant Cyclophosphamide and Antithymocyte Globulin versus Posttransplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis for Peripheral Blood Stem Cell Haploidentical Transplants: Comparison of T Cell and NK Effector Reconstitution

Published:2020-08-03 Issue:5 Volume:205 Page:1441-1448
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Makanga Dhon Roméo,Guillaume Thierry^ORCID,Willem Catherine,Legrand Nolwenn,Gagne Katia,Cesbron Anne^ORCID,Gendzekhadze Ketevan^ORCID,Peterlin Pierre,Garnier Alice,Le Bourgeois Amandine,Béné Marie C.^ORCID,Chevallier Patrice,Retière Christelle^ORCID

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference35 articles.

1. Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies

2. HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

3. Mobilized peripheral blood stem cells versus unstimulated bone marrow as a graft source for T-cell-replete haploidentical donor transplantation using post-transplant cyclophosphamide. [Published erratum appears in 2019 J. Clin. Oncol. 37: 528.];Bashey;J. Clin. Oncol.,2017

4. Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide.;Ruggeri;Cancer,2018

5. Salas, M. Q. S. Prem E. G. Atenafu A. Datt Law W. Lam Z. Al-Shaibani D. Loach D. D. H. Kim F. V. Michelis J. H. Lipton . 2020. Dual T-cell depletion with ATG and PTCy for peripheral blood reduced intensity conditioning allo-HSCT results in very low rates of GVHD. Bone Marrow Transplant.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-transplant cyclophosphamide plus anti-thymocyte globulin lowered serum IL-6 levels compared with post-transplant cyclophosphamide alone after haploidentical hematopoietic stem cell transplantation;2024-09-11

2. Anti-thymocyte globulin combined with post-transplantation cyclophosphamide reduce graft-versus-host disease in hematopoietic stem cell transplantation for pediatric leukemia;Leukemia & Lymphoma;2024-07-07

3. Combination of Anti-thymocyte Globulin with Post-transplant Cyclophosphamide for GVHD Prophylaxis in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation: Systematic Review and Meta-analysis;Transplantation and Cellular Therapy;2024-07

4. Graft-versus-tumor effect of post-transplant cyclophosphamide-based allogeneic hematopoietic cell transplantation;Frontiers in Immunology;2024-06-06

5. Allogeneic hematopoietic stem cell transplant for familial hemophagocytic lymphohistiocytosis: a case report and literature review;Frontiers in Immunology;2024-06-03